Indaptus Therapeutics, Inc.
Develops immunotherapies using engineered bacteria to treat cancer and viral infections.
INDP | NDAQ
Overview
Corporate Details
- ISIN(s):
- US45339J1051
- LEI:
- Country:
- United States of America
- Address:
- 3 COLUMBUS CIRCLE, 10019 NEW YORK
- Website:
- https://indaptusrx.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Indaptus Therapeutics, Inc. is a clinical-stage biotechnology company developing novel immunotherapies to treat cancer and viral infections. The company's proprietary, patented platform is based on the systemic administration of engineered, non-pathogenic bacteria designed to activate both the innate and adaptive immune systems. This approach, which includes its Decoy20 technology, leverages the natural ability of bacteria to stimulate a broad anti-tumor and anti-viral response. Indaptus aims to address diseases with high unmet medical needs by harnessing the body's own immune defenses.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Indaptus Therapeutics, Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Indaptus Therapeutics, Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Indaptus Therapeutics, Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
